Starting April 1, state employees in North Carolina will no longer have insurance coverage for costly weight-loss medications like Wegovy and Zepbound.
Category: Novo Nordisk A/S
-
How Much Do Ozempic and Wegovy Cost? Not What You Think.
Drug companies are making billions from a new class of in-demand weight-loss treatments. But the prices are not what they seem.
-
Lawsuit Challenges Insurance Restrictions on Weight Loss Drugs Like Wegovy
Many employers and government programs won’t cover costly obesity medications. A lawsuit is challenging one such policy.
-
Novo Nordisk’s Ozempic and Wegovy Reshape Denmark’s Economy
Novo Nordisk, the Danish company behind two popular obesity medications, is reaping huge profits and is now responsible for most of the country’s economic growth.
-
Wegovy, the Weight Loss Drug, Relieves Heart Failure Symptoms: Drugmaker’s Study
The drug Wegovy eased issues for people with a type of heart problem, adding to the treatment’s benefits beyond weight loss.
-
California’s Plan for Cheaper Insulin Collides With Big Pharma’s Price Cuts
The New York Times – Business:The state awarded a $50 million contract to produce less costly treatments, but moves by major suppliers might undercut the initiative before any new product emerges.
-
Sanofi Plans to Cut the Price of Insulin
The New York Times – Business:The company is the third of the three major insulin manufacturers that dominate the U.S. market to announce such a move this month.
-
Novo Nordisk Says It Will Slash the Price of Insulin
The New York Times – Business:The company’s decision follows a similar move by its rival, Eli Lilly, this month.